With shares of Facebook (NYSE:FB) trading around $24, is FB an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
T = Trends for a Stock’s Movement
Facebook is engaged in building products to create utility for users, developers, and advertisers. People use Facebook to stay connected with their friends and family, to discover what is going on in the world around them, and to share and express what matters to them to the people they care about. Developers can use the Facebook Platform to build applications and websites that integrate with Facebook to reach its global network of users and to build personalized and social products. Advertisers can engage with more than 900 million monthly active users on Facebook or subsets of its users based on information they have chosen to share. Social networking has been a powerful movement and tool in recent years that has changed the way many companies and consumers operate. Facebook is a pioneer and a leader in the social network trend that looks to be here to stay. Facebook will see rising profits through its engagement with the increasing user base that social networking is seeing in coming years.
Top 10 Safest Companies For 2016: ZIOPHARM Oncology Inc(ZIOP)
ZIOPHARM Oncology, Inc., a biopharmaceutical company, engages in the development and commercialization of small molecule and synthetic biology approaches to cancer therapies in the United States. The company's clinical programs include Palifosfamide, a DNA cross-linker, which is in a phase III clinical trial for the treatment of metastatic soft tissue sarcoma in the front-line setting. ZIOPHARM is also developing Palifosfamide in combination with etoposide and carboplatin in phase I clinical trial to determine safety for initiating a pivotal, adaptive phase III trial in front-line. In addition, the company, in partnership with Intrexon Corporation, is developing DNA-based therapeutics (synthetic biology) that include two phase 1 clinical-stage product candidates, both of which are DNA IL-12 to be turned on/off by an oral activator ligand. Further, it is developing Indibulin, an oral tubulin binding agent, which is in Phase 1/2 for metastatic breast cancer; and Darinaparsin , a mitochondrial- and hedgehog-targeted agent that is in a solid tumor phase I study with oral administration and has been developed intravenously for the treatment of relapsed peripheral T-cell lymphoma. The company was founded in 2003 and is headquartered in New York City, New York.
Advisors' Opinion:- [By Garrett Cook]
In trading on Tuesday, healthcare shares were relative laggards, down on the day by about 0.14 percent. Top losers in the sector included ZIOPHARM Oncology (NASDAQ: ZIOP), down 8.9 percent, and Sanofi (NYSE: SNY), off 9.3 percent.
- [By John Udovich]
Biotech in general has been one of the market�� hottest sectors this year thanks to plenty of mostly good news�along with�new IPOs while small cap biotech stocks Delcath Systems (NASDAQ: DCTH), ZIOPHARM Oncology Inc (NASDAQ: ZIOP), Recro Pharma (NASDAQ: REPH), TetraLogic Pharmaceuticals (NASDAQ: TLOG)�and TNI BioTech (OTCMKTS: TNIB) have also produced their share of news�this week or in recent weeks. Just consider the following:
- [By James E. Brumley]
Four months ago, you could barely give your shares of ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) away. The company announced s on Tuesday, March 26th, that its sarcoma drug Palifosfamide had failed to meet its Phase 3 goals. Shares of ZIOP plunged from $5.13 to $1.82 in a mere day, and were trading as low as $1.51 a week and a half later.
Top 5 Building Product Stocks To Watch Right Now: Kayne Anderson Energy Total Return Fund Inc (KYE)
Kayne Anderson Energy Total Return Fund, Inc. (the Fund) is a non-diversified closed-end investment company. The Fund�� investment objective is to obtain a high total return with an emphasis on current income. The Fund seeks to achieve this objective by investing primarily in securities of companies engaged in the energy industry, principally including publicly-traded energy-related master limited partnerships and limited liability companies taxed as partnerships (MLPs), MLP affiliates, energy-related United States and Canadian royalty trusts and income trusts and other companies that derive at least 50% of their revenues from operating assets used in, or providing energy-related services for, the exploration, development, production, gathering, transportation, processing, storing, refining, distribution, mining or marketing of natural gas, natural gas liquids (including propane), crude oil, refined petroleum products or coal.
Effective December 31, 2006, Kayne Anderson assigned the Investment Management Agreement to its subsidiary, KA Fund Advisors, LLC (the Adviser). The Fund focuses on investing at least 80% of the aggregate of its net assets and borrowings (total assets) in securities of Energy Companies. The Fund invests in equity securities, such as common stocks, preferred stocks, convertible securities, warrants, depository receipts, and equity interests in MLPs, MLP affiliates, royalty trusts and other Energy Companies.
Advisors' Opinion:- [By Robert Rapier]
We got several questions about Kayne Anderson Energy Total Return Fund (NYSE: KYE) during the chat. The main advantage of closed-end MLP funds is the diversification they provide, along with the convenience of a 1099 miscellaneous income tax form instead of having to deal with K-1 forms from each individual MLP. This makes a closed-end MLP fund a more attractive option for an IRA.
Top 5 Building Product Stocks To Watch Right Now: Gigamon Inc (GIMO)
Gigamon Inc., incorporated on January 2, 2009, has developed solution that delivers visibility and control of traffic across networks. Its solution, which it refers to as its traffic visibility fabric, consists of distributed network appliances that provide an advanced level of network traffic intelligence. Its fabric enables information technology (IT) organizations to forward traffic from network infrastructure to management, analysis, compliance and security tools in a manner that is optimized for specific uses or locations. Its flow mapping technology that identifies and directs incoming traffic to single or multiple tools based on user-defined rules implemented from a centralized management console. Its products consist of GigaVUE, GigaSECURE, GigaSMART and GigaTAP products. Its traffic visibility fabric is deployed by enterprises and service providers. Its traffic visibility fabric is built on the GigaVUE family of products.
The Company generates product revenue primarily from sales of perpetual software licenses installed on physical appliances for its traffic visibility fabric solutions to channel partners, including distributors and resellers, as well as directly to end user customers. The Company generates services revenue primarily from the sale of maintenance and support services for its products. As of March 31, 2012, the Company had sold products to over 825 end user customers across many vertical markets, including the United States retailers, United States banks and financial services companies, United States integrated telecommunication service providers, United States managed healthcare providers, United States cable and satellite providers and global securities and commodities exchanges. It offers purpose-built physical appliances that are integrated with its software and enable its end user customers to design traffic visibility fabric architectures optimized for a range of scale and performance requirements from one gigabit appliances to one terabit chassis-based solu! tions.
Its appliances range from a single rack unit appliance to a modular multi-slot chassis that accommodates a range of its line cards. The GigaVUE product family consists of G Series and H Series of products. The GigaVUE G Series consists of a range of purpose-built, small form-factor traffic visibility appliances. Its GigaSECURE products provide in-line packet distribution specifically designed for use with security-based tools, such as intrusion prevention systems (IPS). The GigaSECURE products are designed to support two-way traffic communications and provide bypass protection allowing packets to be distributed to multiple IPS devices where they are screened, and then aggregated back together for entry back to the network. The GigaVUE H Series utilizes a robust Linux-based operating platform enabling configurations. The series includes both large blade-based chassis configurations and a fixed configuration product specifically designed to aggregate 10 gigabit traffic links together.
The Company also offers ongoing technical support with its hardware and software products. Its primary support offering, SupportCARE, provides two-tiered support levels, including premium-level support coverage. It offers end user customers ongoing maintenance services for both hardware and software, which enables them to receive ongoing software updates, upgrades, bug fixes and repairs. It also offers DesignCARE in the North America region, which provides end user customers with professional services that range from the architectural design of a Traffic Visibility Fabric for their customized requirements to the complete implementation and configuration of GigaVUE appliances across multiple locations. Its support personnel are based in Milpitas, California and Reading, United Kingdom.
The Company competes with Cisco Systems, Inc. and Juniper Networks, Inc.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading UP
Gigamon (NYSE: GIMO) shares shot up 7.77 percent to $17.33 after the company announced Q1 results. Gigamon reported a Q1 loss of $0.07 per share on revenue of $31.80 million. Needham upgraded the stock from Buy to Strong Buy. - [By Jake L'Ecuyer]
Equities Trading UP
Gigamon (NYSE: GIMO) shares shot up 6.59 percent to $17.14 after the company announced Q1 results. Gigamon reported a Q1 loss of $0.07 per share on revenue of $31.80 million. Needham upgraded the stock from Buy to Strong Buy.
Top 5 Building Product Stocks To Watch Right Now: iShares 1-3 Year Credit Bond ETF (CSJ)
iShares Lehman 1-3 Year Credit Bond Fund (the Fund) seeks investment results that correspond to the price and yield performance of the investment-grade credit sector of the United States bond market as defined by the Lehman Brothers 1-3 Year U.S. Credit Index (the Index). The Index measures the performance of investment-grade United States credit securities, corporate debt and sovereign, local authority and non-United States agency bonds that are United States dollar denominated.
The Fund invests in a representative sample of the securities in the Index, which has a similar investment profile as the Index. The Index includes investment grade United States credit securities that have a remaining maturity of greater than or equal to one year and less than three years, and have more than $250 million or more of outstanding face value. Barclays Global Fund Advisors serves as an advisor to the Fund.
Advisors' Opinion:- [By GURUFOCUS]
In addition to individual stocks several funds pay a monthly dividend. Below is a sampling of these:
Monthly Bond Funds- iShares Barclays 1-3 Year Credit Bond (CSJ) | Yield: 1.29%
- Vanguard Short-Term Bond ETF (BSV) | Yield: 1.25%
- Vanguard Intermediate-Term Bond ETF (BIV) | Yield: 2.96%
- Vanguard Long-Term Bond ETF (BLV) | Yield: 4.42%
No comments:
Post a Comment